20/20 Biolabs, Inc. (AIDX) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering 20/20 Biolabs, Inc. (AIDX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For 20/20 Biolabs, Inc., analysts forecast revenue rising from $2.62M in 2026 to $61.58M in 2030; the average estimate for 2030 earnings per share is −$0.41; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
20/20 Biolabs, Inc. (AIDX) forecast — frequently asked questions
What is the analyst price target for 20/20 Biolabs, Inc.?
Analysts covering 20/20 Biolabs, Inc. (AIDX) have a consensus price target of $5.00, 2531.6% above the current price of $0.19. Published targets range from $5.00 to $5.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for 20/20 Biolabs, Inc.'s earnings?
The average analyst estimate for 20/20 Biolabs, Inc. (AIDX) earnings per share in 2030 is -0.41, with individual estimates between -0.41 and -0.41.
How much revenue is 20/20 Biolabs, Inc. expected to make?
Analysts forecast 20/20 Biolabs, Inc. (AIDX) revenue of $61.58M in 2030, based on 1 published estimates.
How many analysts cover AIDX?
1 analyst contribute estimates for 20/20 Biolabs, Inc. (AIDX). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Care Facilities stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.